Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 240 Lymphoma 178 Lymphoma, Large B-Cell, Diffuse 172 Precursor Cell Lymphoblastic Leukemia-Lymphoma 87 Lymphoma, Follicular 79 Lymphoma, Non-Hodgkin 73 Burkitt Lymphoma 66 Multiple Myeloma 64 Leukemia 57 Hodgkin Disease 45 Lymphoma, Mantle-Cell 41 Neoplasms 34 Lymphoma, T-Cell, Peripheral 31 Lymphoma, B-Cell 30 Lymphoma, B-Cell, Marginal Zone 28 Lymphoma, Large-Cell, Anaplastic 26 Neoplasm Metastasis 25 Lymphoma, Large-Cell, Immunoblastic 24 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22 Leukemia, Lymphocytic, Chronic, B-Cell 22 Neoplasms, Plasma Cell 21 Recurrence 20 Immunoblastic Lymphadenopathy 15 Dendritic Cell Sarcoma, Interdigitating 15 Lymphoma, T-Cell 14 Leukemia, Biphenotypic, Acute 10 Waldenstrom Macroglobulinemia 9 Blast Crisis 9 Primary Myelofibrosis 8 Myelodysplastic Syndromes 8

Interventions

Methylprednisolone 4 Etanercept 2 Bronchoscopy 2 Bronchoalveolar Lavage 2 Blood Specimen Collection 2 ziprasidone 1 tocilizumab 1 pirfenidone 1 ceftolozane, tazobactam drug combination 1 Zolpidem 1 XAV-19 1 X-Rays 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Ultrasonography 1 Tranexamic Acid 1 Tobramycin 1 Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Surveys and Questionnaires 1 Standard of Care 1 Spironolactone 1 Sodium Bicarbonate 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Ribavirin 1 Prednisone 1 Piperacillin, Tazobactam Drug Combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pneumonia × Prednisone × Clear all

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡